Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Temporal trends in the incidence and mortality of pulmonary arterial hypertension in the United Kingdom over the past 3 decades

View through CrossRef
Abstract Introduction Pulmonary arterial hypertension (PAH) imposes significant burden due to the associated morbidity and mortality. Evaluating the temporal trends in the incidence and mortality of PAH is of paramount importance as it enables risk stratification and prompt recognition of emerging trends. Methods Temporal trends in the incidence and mortality of PAH in the United Kingdom (UK) over the period 1990-2019 were evaluated by retrieving data, including the age-standardized incidence rate (ASIR) and the age-standardized mortality rate (ASMR), from the Global Burden of Disease database. Joinpoint Analysis was utilized tocalculate the Annual Percent Change (APC) and the Average Annual Percent Change(AAPC). Trends were evaluated across the UK, the 4 nations within the UK (England,Wales, Northern Ireland, and Scotland), and across the different regions within England. Results Over a span of 30 years, an estimated total of 6,942 cases of PAH with a female predominance 53.9% were reported across the UK. A statistically significant decline in the ASIR across the UK was noted with an AAPC of -0.16 (95%CI -0.17 to -0.15, p<0.001). Gender stratification revealed a statistically significant decline in the ASIR in both males and females, with the more prominent decrease noted in the latter with an AAPC of -0.23. Stratification on a national level revealed a statistically significant decrease in the ASIR across England, Scotland, Northern Ireland, and Wales with the highest decline observed in Wales with an AAPC of -0.44 (95CI% -0.45 to -0.44, p<0.001). Across England, a statistically significant decline was noted in all of the regions, except for North West England which encountered a statistically insignificant decline with an AAPC of -0.014 (95CI% -0.31 to 0.006, p=0.14). In terms of PAH-related mortalities, an estimated total of 3,381 deaths with a female predominance of 66.6% were reported. A statistically significant decline in the ASMR was noted across the UK with an AAPC of -0.84 (95%CI -0.92 to -0.77, p<0.001). Gender stratification revealed a statistically significant decline in both females and males, with the more prominent decline noted in the latter. Stratification on a national level revealed a statistically significant decline across all 4 nations, with the most prominent decline noted in Northern Ireland with an AAPC of -1.12 (95%CI -1.30 to -1.02, p<0.001). Across England, a statistically significant decline was noted across all regions, with Greater London witnessing the greatest decline with an AAPC of -1.21. Conclusion During 1990-2019, pulmonary arterial hypertension has witnessed a statistically significant decline in incidence and mortality across the UK. These findingswarrant comparison with other developed and developing countries to identify the factors leading to such promising decline.
Title: Temporal trends in the incidence and mortality of pulmonary arterial hypertension in the United Kingdom over the past 3 decades
Description:
Abstract Introduction Pulmonary arterial hypertension (PAH) imposes significant burden due to the associated morbidity and mortality.
Evaluating the temporal trends in the incidence and mortality of PAH is of paramount importance as it enables risk stratification and prompt recognition of emerging trends.
Methods Temporal trends in the incidence and mortality of PAH in the United Kingdom (UK) over the period 1990-2019 were evaluated by retrieving data, including the age-standardized incidence rate (ASIR) and the age-standardized mortality rate (ASMR), from the Global Burden of Disease database.
Joinpoint Analysis was utilized tocalculate the Annual Percent Change (APC) and the Average Annual Percent Change(AAPC).
Trends were evaluated across the UK, the 4 nations within the UK (England,Wales, Northern Ireland, and Scotland), and across the different regions within England.
Results Over a span of 30 years, an estimated total of 6,942 cases of PAH with a female predominance 53.
9% were reported across the UK.
A statistically significant decline in the ASIR across the UK was noted with an AAPC of -0.
16 (95%CI -0.
17 to -0.
15, p<0.
001).
Gender stratification revealed a statistically significant decline in the ASIR in both males and females, with the more prominent decrease noted in the latter with an AAPC of -0.
23.
Stratification on a national level revealed a statistically significant decrease in the ASIR across England, Scotland, Northern Ireland, and Wales with the highest decline observed in Wales with an AAPC of -0.
44 (95CI% -0.
45 to -0.
44, p<0.
001).
Across England, a statistically significant decline was noted in all of the regions, except for North West England which encountered a statistically insignificant decline with an AAPC of -0.
014 (95CI% -0.
31 to 0.
006, p=0.
14).
In terms of PAH-related mortalities, an estimated total of 3,381 deaths with a female predominance of 66.
6% were reported.
A statistically significant decline in the ASMR was noted across the UK with an AAPC of -0.
84 (95%CI -0.
92 to -0.
77, p<0.
001).
Gender stratification revealed a statistically significant decline in both females and males, with the more prominent decline noted in the latter.
Stratification on a national level revealed a statistically significant decline across all 4 nations, with the most prominent decline noted in Northern Ireland with an AAPC of -1.
12 (95%CI -1.
30 to -1.
02, p<0.
001).
Across England, a statistically significant decline was noted across all regions, with Greater London witnessing the greatest decline with an AAPC of -1.
21.
Conclusion During 1990-2019, pulmonary arterial hypertension has witnessed a statistically significant decline in incidence and mortality across the UK.
These findingswarrant comparison with other developed and developing countries to identify the factors leading to such promising decline.

Related Results

Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
<p dir="ltr"><b>BACKGROUND:</b><br><br>Most forms of pulmonary hypertension carry unsatisfactory prognosis with the notable exception of chronic throm...
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
Multimodality imaging of chronic thromboembolic pulmonary hypertension : new insights into old challenges
<p dir="ltr"><b>BACKGROUND:</b><br><br>Most forms of pulmonary hypertension carry unsatisfactory prognosis with the notable exception of chronic throm...
GW24-e3137 The etiology investigate of hypertension incidence in children
GW24-e3137 The etiology investigate of hypertension incidence in children
Objectives Through retrospective analysis of related factors of children’s hypertension what is composed by primary hypertension and secondary hypertension diseas...
Incidence of Pulmonary Hypertension in the Echocardiography Referral Population
Incidence of Pulmonary Hypertension in the Echocardiography Referral Population
Rationale: Incidence rates for pulmonary hypertension using diagnostic data in patients with cardiopulmonary disease are not known. Objectives: To determine incidence rates of, ris...
MO746CARDIAC REMODELING AND PULMONARY HYPERTENSION IN HEMODIALYSIS PATIENTS
MO746CARDIAC REMODELING AND PULMONARY HYPERTENSION IN HEMODIALYSIS PATIENTS
Abstract Background and Aims An important predictor of cardiovascular mortality and morbidity in hemodialysis patients is left v...
Characteristics of Infants With Congenital Diaphragmatic Hernia Who Need Follow-Up of Pulmonary Hypertension
Characteristics of Infants With Congenital Diaphragmatic Hernia Who Need Follow-Up of Pulmonary Hypertension
Objectives: Pulmonary hypertension is one of the main causes of mortality and morbidity in patients with congenital diaphragmatic hernia. Currently, it is unknown wheth...
Respiratory rate modulation improves symptoms in patients with pulmonary hypertension
Respiratory rate modulation improves symptoms in patients with pulmonary hypertension
Background: Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension are chronic diseases with a severe symptom burden. Common symptoms are dyspnoea at lig...
Faktor Yang Berhubungan Dengan Hipertensi Pada Lansia di Puskesmas Sialang Buah Kec. Teluk Mengkudu Kab. Serdang Bedagai Tahun 2023
Faktor Yang Berhubungan Dengan Hipertensi Pada Lansia di Puskesmas Sialang Buah Kec. Teluk Mengkudu Kab. Serdang Bedagai Tahun 2023
Hypertension is a non-communicable disease which is a very serious health problem today and is the biggest cause of stroke, both systolic and diastolic blood pressure. The incidenc...

Back to Top